INTRODUCTION
Narcolepsy is characterized by excessive daytime sleepiness, cataplexy and pathological manifestations of rapid eye movement (REM) sleep, including hypnagogic hallucinations, sleep paralysis and sleep-onset REM sleep. Narcolepsy affects 0.16-0.18% of the general population in Japan and 0.02-0.06% of the populations in the United States and Europe (1, 2) . Two independent groups have shed light on the pathogenesis of animal narcolepsy. Disruption of the canine hypocretin (orexin) receptor 2 gene causes autosomal recessive canine narcolepsy (3) , and a preprohypocretin knockout mouse model also exhibits narcolepsy-like behaviors and electroencephalographic activity consistent with rapid transitions into REM sleep (4) . In humans, hypocretin-1 is reduced or undetectable in the cerebrospinal fluid of narcoleptic patients and postmortem examination has shown a dramatic reduction of hypocretin producing neurons in the hypothalamus (5, 6) . In contrast to animal models, narcolepsy in human is not a simple genetic disorder. Mutations in hypocretin-gene do not contribute considerably to narcolepsy susceptibility in humans (7, 8) , except for in rare cases (9) . The concordance rate of monozygotic twins for narcolepsy is 20-30%, and 1-2% of the first-degree relatives of a narcoleptic patient are also affected by this disease. Relative risk in first-degree family members of narcoleptic patients is thus 10-to 40-fold higher than the general population (1) . Therefore, multiple factors, including genetic and environmental factors, are involved in the development of human narcolepsy.
In 1984, Honda and Juji found that all narcoleptic patients with cataplexy in Japan carried the human leukocyte antigen HLA-DR2 (10), or at the sequence level HLA-DRB1 * 15:01-DQB1 * 06:02 (11) . Almost all Japanese patients carry this haplotype, whereas 12% of the general Japanese population carries it. Similar findings have been made in Europeans, Chinese, Koreans and AfricanAmericans narcoleptic patients (11) (12) (13) (14) . In African Americans, narcolepsy is associated with other DRB1-DQB1 haplotypes such as DRB1 (11, 13, 14, 18, 19) . Individuals with DQB1 * 03:01 are at increased risk in the European, Chinese, Korean and Japanese populations (11) (12) (13) (14) 20) . DQB1 * 05:01 frequencies of narcoleptic patients are much lower than those of healthy controls in many populations, although the differences might not be statistically significant after multiple testing correction (11) (12) (13) (14) . In the present study, to test associations of DQB1 alleles other than DQB1
* 06:02, we extended our analysis for HLA-DQB1 to a large sample of Japanese narcoleptic patients. In addition, multiple HLA class I and class II alleles independently contribute to susceptibility to some autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes and Grave's disease (21) (22) (23) (24) . Therefore, to identify potential further association signals distributed across the HLA region, we performed a conditional analysis controlling for the effect of DQB1 alleles by using single-nucleotide polymorphism (SNP) chip data.
RESULTS

HLA-DQB1 analysis
HLA-DQB1 data from 664 Japanese narcoleptic patients and 3131 Japanese control subjects were examined. Allele frequencies for HLA-DQB1 of narcoleptic patients and controls are shown in Table 1 (18) , and it showed the same tendency but did not reach a significant level in the present study (P ¼ 0.26, OR ¼ 0.25). In addition, combinations of DQB1 * 06:02 and other DQB1 alleles were compared between DQB1 * 06:02 heterozygous cases (n ¼ 580) and controls (n ¼ 196). We similarly observed a susceptibility effect of DQB1 * 03:02/DQB1 * 06:02 (P ¼ 1.6 × 10
24
, OR ¼ 2.94) despite the reduction in sample size of the controls (Table 3 
Conditional analysis outside of the HLA-DQB1 locus
To assess whether there were other independent HLA associations outside of HLA-DQB1, we tested 917 SNPs in the HLA region, genotyped by the Genome-Wide Human SNP Array 6.0, in 398 cases and 418 controls passing the sample QC filters (details in Materials and Methods). A case -control analysis first revealed that SNP rs7744293 showed the strongest association with narcolepsy (P ¼ 4.2 × 10 286 , OR ¼ 13.56) (Fig. 1A) . SNP rs7744293 was located in 270 kb downstream of HLA-DQB1 and was in strong linkage disequilibrium (LD) with DQB1
* 06:02 (r 2 ¼ 0.84), indicating that SNP rs7744293 showed a secondary association resulting from LD with DQB1 * 06:02. Then, we performed a conditional analysis controlling for the effect of DQB1 alleles by using SNPs in the HLA region for screening purposes. We observed the most significant association at HLA-DPB1 in the HLA class II region (SNP rs3117242, P ¼ 4.1 × 10
25
, OR ¼ 2.45) ( Fig. 1B and C ). The corrected P-value was calculated by using the Bonferroni correction and was still significant (the number of comparisons ¼ 917, Pc ¼ 4.1 × 10
/917 ¼ 0.038). No residual association at HLA-DQB1 was detected after the conditional analysis (P . 10
23
). Therefore, HLA-DPB1 was further typed in 571 cases and 1418 controls. After conditioning on the effects of DQB1 alleles, DPB1 * 05:01 was marginally associated with narcolepsy ). These data suggest that the DPB1 * 05:01 association is independent of the DQB1 associations.
DISCUSSION
We have examined the influence that HLA alleles other than DQB1 * 06:02 have on susceptibility to narcolepsy. First, HLA-DQB1 alleles of 664 narcoleptic patients with cataplexy and 3131 control subjects were analyzed ( Table S5 ). No significant differences between them were observed, indicating that the significant association with DQB1 * 03:02 would not be a secondary association resulting from LD with DRB1 alleles but rather that DQB1 * 03:02 would have a primary effect. An HLA analysis of 200 Chinese narcoleptic patients versus 100 controls found that not DQB1 * 03:02 but DQB1 * 03:01 was significantly associated with narcolepsy (12) . There were no reports of significant association between DQB1 * 03:02 and narcolepsy in Koreans (13, 14) . It is interesting that associated HLA alleles with narcolepsy differ between populations. The DQB1 * 03:02 association in the present study might possibly be specific to Japanese narcolepsy. Several factors, including differences in study sample size, ethnicity and environmental factors, could contribute to this difference. Large-scale studies in many populations will be required to understand the complex relationships between narcolepsy and HLA alleles. Recently, it has been reported that AS03-adjuvanted AH1N1 vaccine increased the risk of narcolepsy in European countries (26 -28) . In addition, it has been reported that the 2009 H1N1 winter influenza pandemic in China was a trigger for narcolepsy independently of the vaccine (29) . These reports also suggested that various genetic and environmental factors can lead to the complex etiology of narcolepsy. In further genetic studies, analyses including information of these environmental factors should be performed to identify novel genetic factors.
Five HLA-DQB1 alleles except for DQB1 * 06:02 were significantly associated with narcolepsy. Considerations of HLA analysis include that when one HLA allele has a very large difference in frequency between cases and controls, frequency distributions of other HLA alleles in the same locus can be highly affected. Actually, since almost all narcoleptic patients carry DQB1
* 06:02, frequencies of the other DQB1 alleles in the patients became totally lower than those of healthy controls (Table 1) . It is necessary to control for the effect of DQB1 * 06:02 to test the effects of additional DQB1 alleles. Therefore, frequencies and ORs were calculated for the DQB1 alleles carried on the non-DQB1 * 06:02 chromosome. As a result, DQB1 * 03:02, DQB1 * 04:01 and DQB1 * 05:02 frequencies were significantly higher in the patients compared with the controls (Table 2 ). In the present study, combinations of DQB1 * 06:02 and other DQB1 alleles were also compared between DQB1 * 06:02 heterozygous cases (n ¼ 580) and controls (n ¼ 196) to directly control the effect of DQB1 * 06:02 (Table 3) . Since DQB1 * 06:02 allele frequency is not high in the Japanese population, the number of controls was decreased from the analysis in Table 2 . However, a significant association between DQB1 * 03:02/DQB1 * 06:02 and narcolepsy was confirmed. Furthermore, dominant protective effects of DQB1 * 06:01 and DQB1 * 05:01 were revealed by the DQB1 * 06:02 heterozygous comparison. In addition to the analysis of DQB1 alleles located trans of DQB1 * 06:02 in Table 2 , the DQB1 * 06:02 heterozygous comparison is important to understand the effects of the other DQB1 alleles.
We tested whether there were other independent HLA associations outside of HLA-DQB1. First, 917 SNPs in the HLA region were analyzed in 398 cases and 418 controls. After controlling for the effects of DQB1 alleles, we found SNP rs3117242 OR, odds ratio; L95, U95, lower and upper limits of confidence interval at 95%. at HLA-DPB1 to be associated with narcolepsy (OR ¼ 2.45) (Fig. 1B and C) . The overall LD between HLA-DQB1 and -DPB1 is much lower (30, 31) . Figure 1A also indicated that two recombination hot spots exist between HLA-DQB1 and -DPB1. We performed HLA-DPB1 typing and a conditional analysis with a larger sample size (571 cases and 1418 controls) in the expectation of a significant association with narcolepsy. DPB1 * 05:01 showed a marginal association (P ¼ 8.1 × 10 23 , OR ¼ 1.39). However, the OR of DPB1 * 05:01 was lower than that of SNP rs3117242. To confirm whether DPB1 * 05:01 and/ or SNP rs3117242 is truly associated with narcolepsy, further studies with larger sample sizes are required.
The HLA association alone is not responsible for the development of narcolepsy (11) . GWASs have actually revealed susceptibility loci for narcolepsy (32) (33) (34) (35) . Interestingly, a GWAS has identified an SNP in carnitine palmitoyltransferase 1B (CPT1B) encoding an enzyme involved in the b-oxidation of long-chain fatty acids (35) . The mRNA expression levels of CPT1B have been associated with this SNP. In addition, acylcarnitine levels are abnormally low in narcoleptic patients (36, 37) . Taken together, not only the autoimmunity mechanism but also fatty acid metabolism contributes to the pathophysiology of narcolepsy which is a multifactorial disease. Further genetic research that includes a GWAS and sequencing are required to search for novel genetic factors in narcolepsy to understand its pathogenesis.
The present study demonstrates complex HLA effects in narcolepsy. Several DQB1 alleles located trans of DQB1 * 06:02 influenced susceptibility or resistance to narcolepsy, among which DQB1 * 03:02 had susceptibility effects on narcolepsy. We hope that precise understanding of genetic associations between HLA and narcolepsy will contribute to elucidating the role of HLA in the pathogenesis of narcolepsy.
MATERIALS AND METHODS
Subjects
Narcolepsy with cataplexy (narcolepsy) was diagnosed according to the International Classification of Sleep Disorders, 2nd edition. The sample comprised 664 HLA-DQB1
* 06:02 positive-narcoleptic patients. All subjects gave written informed consent. This study was approved by the local institutional review boards at participating institutions. Regarding healthy controls, we utilized HLA data from the HLA Foundation Laboratory (n ¼ 1000), an evolutionary analysis of HLA genes (30) (n ¼ 418), the joint report of the 11th Japan HLA Workshop (n ¼ 1197) and the Japanese Society for Histocompatibility and Immunogenetics databank (n ¼ 516) (http://jshi.umin.ac.jp/m hc/mhc_vol06 -10/v08nakajima_all.pdf). All of the patients and controls were Japanese. 
Genotyping
Typing for HLA-DQB1 and -DPB1 loci was performed by a Luminex Multi-Analyte Profiling system (xMAP) with WAKFlow HLA typing kits (Wakunaga Pharmaceutical Co., Ltd) and LABType SSO HLA kits (One Lambda, Inc).
SNP genotyping was performed with the Genome-Wide Human SNP Array 6.0 in 413 narcoleptic patients and 1610 healthy controls according to the manufacturer's protocol (Affymetrix). A principal components analysis (PCA) was performed by using the computer program EIGENSTRAT to correct for the effect of population stratification (38) . Genotype data from the Phase II HapMap database consisting of 45 Japanese (JPT), 45 Han Chinese (CHB) and 90 CEPH (Utah residents with ancestry from northern and western Europe) individuals were used for the EIGENSTRAT analysis as references. Four outliers from the cases and 45 outliers from the controls who were deviated from the East Asian (JPT+CHB) cluster were removed, and three modest outliers from the controls were also removed because of deviations from their own clusters (Supplementary Material, Fig. S1A and S1B). Then, we confirmed that no cases or controls were classified as outliers in the PCA (Supplementary Material, Fig. S1C ). Population stratification was accessed by calculating the genomic inflation factor (l) after filtering and removing associated SNPs between cases and controls; the l of this dataset was 1.03, and there was little evidence for residual population stratification. This step left 409 cases and 1562 controls. Of these individuals, 398 cases and 418 controls carrying the HLA-DQB1 type were analyzed. The l was calculated to be 1.02. Regarding quality control of SNP genotype data, we excluded SNPs that showed a minor allele frequency of ,5% (in cases and controls), genotyping call rates of ,99% (in cases and controls), and SNPs with P-values of less than the threshold of the Hardy -Weinberg equilibrium test (P , 10 23 in controls). Finally, 917 SNPs in the HLA region were selected (chr.6; nucleotide position: 29 500 000-33 500 000; build 36).
Statistical analysis
Comparisons of HLA allele and carrier (phenotype) frequencies between cases and controls were performed by using the x 2 test or Fisher exact test as appropriate. To account for multiple tests, the resulting P-values were adjusted by the number of HLA alleles with allele frequencies ≥0.5% in controls (11 for DQB1 alleles and 11 for DPB1 alleles). We set the significance level to be P , 4.5 × 10 23 for HLA-DQB1 and -DPB1 analyses. An OR for DQB1 * 06:02 heterozygotes was calculated with DQB1 * 06:02 homozygotes being used as the referent to confirm that DQB1 * 06:02 homozygosity greatly increases narcolepsy susceptibility. Then, to compare DQB1 alleles located trans to DQB1 * 06:02 between narcoleptic subjects and control subjects, frequencies and ORs were calculated for the alleles carried on the non-DQB1 * 06:02 chromosome. If any of the four cells were zero, the Woolf-Haldane correction was applied (adding 0.5 to all cells) to calculate ORs. The RPE method was applied to identify associations sequentially according to their strength (25) . The overall frequency distribution of all alleles of HLA-DQB1 in cases was compared with the distribution in controls by using the x 2 test. HLA-DQB1 alleles with the strongest association were sequentially removed from the analysis until no significant overall deviation was observed.
Regarding HLA data for healthy controls, the joint report of the 11th Japan HLA Workshop (n ¼ 1197) and the Japanese Society for Histocompatibility and Immunogenetics databank (n ¼ 516) provided only HLA allele counts; therefore, statistical analyses based on carrier counts were performed by using HLA data from the HLA Foundation Laboratory (n ¼ 1000) and an evolutionary analysis of HLA genes (30) (n ¼ 418) as healthy controls. To identify independent associations outside of HLA-DQB1 in the HLA region, conditional logistic regression analysis was performed for SNPs and HLA alleles. This analysis was performed as implemented in Plink software (39) , conditioning on HLA-DQB1 to each of the other SNPs and HLA alleles with allele frequencies ≥5%. We included DQB1 alleles with allele frequencies ≥5% as covariates. Manhattan-plots were generated by using LocusZoom (40) .
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
